Traditional Chinese medicine in the era of immune checkpoint inhibitor: theory, development, and future directions
Abstract Immune checkpoint inhibitors (ICIs) have revolutionized cancer management and have been widely applied; however, they still have some limitations in terms of efficacy and toxicity. There are multiple treatment regimens in Traditional Chinese Medicine (TCM) that play active roles in combinat...
Kaydedildi:
Asıl Yazarlar: | Yi-xuan Yu (Yazar), Shuo Wang (Yazar), Zhe-ning Liu (Yazar), Xu Zhang (Yazar), Zi-xin Hu (Yazar), Hui-jing Dong (Yazar), Xing-yu Lu (Yazar), Jia-bin Zheng (Yazar), Hui-juan Cui (Yazar) |
---|---|
Materyal Türü: | Kitap |
Baskı/Yayın Bilgisi: |
BMC,
2023-05-01T00:00:00Z.
|
Konular: | |
Online Erişim: | Connect to this object online. |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|
Benzer Materyaller
-
miRNA-Based Therapeutics in the Era of Immune-Checkpoint Inhibitors
Yazar:: Florian Huemer, ve diğerleri
Baskı/Yayın Bilgisi: (2021) -
Immune checkpoint inhibitor-induced acute tubulointerstitial nephritis
Yazar:: Hui Zhuan Tan, ve diğerleri
Baskı/Yayın Bilgisi: (2022) -
The Strategies and Mechanisms of Immune Checkpoint Inhibitors for Brain Metastases in NSCLC
Yazar:: Ji Li, ve diğerleri
Baskı/Yayın Bilgisi: (2022) -
Immune approaches beyond traditional immune checkpoint inhibitors for advanced renal cell carcinoma
Yazar:: Albert Jang, ve diğerleri
Baskı/Yayın Bilgisi: (2023) -
Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
Yazar:: Rilan Bai, ve diğerleri
Baskı/Yayın Bilgisi: (2020)